1097-0142/asset/cover.gif?v=1&s=a7299bc18f075294c232ade468773cd0672bd470 "Cancer")
Fax: (713) 794-4385
1097-0142/asset/olbannerleft.gif?v=1&s=ca681f5719430b26e1bc15e9ea4c9fc0a7110104)
1097-0142/asset/olbannerright.gif?v=1&s=8142566facf7e76aef9be6c51162a2e920b3b9f9)
Original Article
You have full text access to this OnlineOpen article
Is breast cancer survival improving?
Trends in survival for patients with recurrent breast cancer diagnosed from 1974 through 2000
Article first published online: 10 NOV 2003
DOI: 10.1002/cncr.11859
Copyright © 2003 American Cancer Society
Additional Information
How to Cite
Giordano, S. H., Buzdar, A. U., Smith, T. L., Kau, S.-W., Yang, Y. and Hortobagyi, G. N. (2004), Is breast cancer survival improving?. Cancer, 100: 44–52. doi: 10.1002/cncr.11859
Publication History
- Issue published online: 17 DEC 2003
- Article first published online: 10 NOV 2003
- Manuscript Accepted: 30 SEP 2003
- Manuscript Revised: 26 SEP 2003
- Manuscript Received: 29 AUG 2003
Funded by
- Nellie B. Connally Breast Cancer Research Fund
- Abstract
- Article
- References
- Cited By
Cited in:
- CrossRef
This article has been cited by:
- 1, , , , , , , , , , , , , , Exemestane versus anastrozole as front-line endocrine therapy in postmenopausal patients with hormone receptor-positive, advanced breast cancer, Cancer, 2012, 118, 1Direct Link:
- 2, From improved survival to potential cure in patients with metastatic breast cancer, Breast Cancer, 2012,
- 3, , , , , , , , , , , , , , , , , Possible clinical cure of metastatic breast cancer: lessons from our 30-year experience with oligometastatic breast cancer patients and literature review, Breast Cancer, 2012,
- 4, , , , , Prognostic factors for survival after first recurrence in breast cancer: a retrospective analysis of 252 recurrent cases at a single institution, Breast Cancer, 2012,
- 5, , , , , , , Quality of Life in Long-Term Survivors of Metastatic Breast Cancer, Clinical Breast Cancer, 2012, 12, 2, 119
- 6, , , , , , , The use of bevacizumab among women with metastatic breast cancer: A survey on clinical practice and the ongoing controversy, Cancer, 2012, 118, 11Direct Link:
- 7, , Treatment of Stage IV Breast Cancer with Intact Primary Tumor: A Case for Resection?, Current Breast Cancer Reports, 2012,
- 8
- 9, , , , , , , An all-oral combination of metronomic cyclophosphamide plus capecitabine in patients with anthracycline- and taxane-pretreated metastatic breast cancer: a phase II study, Cancer Chemotherapy and Pharmacology, 2011, 69, 2, 515
- 10
- 11, , , , , , , , Can patients with metastatic breast cancer be cured after introduction of newer and more effective agents?, Breast Cancer, 2011,
- 12, , , Current strategy for triple-negative breast cancer: appropriate combination of surgery, radiation, and chemotherapy, Breast Cancer, 2011, 18, 3, 165
- 13, , , , , , Diagnostik und Therapie von Wirbelsäulenmetastasen, Der Orthopäde, 2011, 40, 2, 185
- 14, , , , Does primary tumor resection improve outcomes for patients with incurable advanced breast cancer?, The Breast, 2011, 20, 6, 543
- 15, , , Eradication of breast cancer cells in patients with distant metastasis: the finishing touches?, Breast Cancer, 2011,
- 16, , , , , , , , Evaluating the impact of Relative Total Dose Intensity (RTDI) on patients' short and long-term outcome in taxane- and anthracycline-based chemotherapy of metastatic breast cancer- a pooled analysis, BMC Cancer, 2011, 11, 1, 131
- 17, , , , , Hepatic resection for metastatic breast cancer: A systematic review, European Journal of Cancer, 2011, 47, 15, 2282
- 18, , Improvement of survival and prospect of cure in patients with metastatic breast cancer, Breast Cancer, 2011,
- 19, Introduction: Current and Future Approaches to Chemotherapy in Patients With Resistant Breast Cancer, Seminars in Oncology, 2011, 38, S1
- 20, , , , , , Isolated Sternal Involvement in Breast Cancer: Is it Truly Stage IV Disease?, Clinical Breast Cancer, 2011, 11, 3, 191
- 21, , , , , , Isolated Sternal Involvement in Breast Cancer: Is it Truly Stage IV Disease?, Clinical Breast Cancer, 2011,
- 22
- 23, , , , , , , , , , Late lines of treatment benefit survival in metastatic breast cancer in current practice?, The Breast, 2011, 20, 6, 574
- 24, , , , , , , Prognostic factors for stage IV hormone receptor-positive primary metastatic breast cancer, Breast Cancer, 2011,
- 25, , , , , , , , , , Prognostic Value of Initial Tumor Parameters After Metastatic Relapse, Cancer Investigation, 2011, 29, 9, 635
- 26, , , , , , , , , , Significant survival improvement of patients with recurrent breast cancer in the periods 2001-2008 vs. 1992-2000, BMC Cancer, 2011, 11, 1, 118
- You have free access to this content27, , , , , , , , , , , , Spontaneous immunogenicity of ribosomal P0 protein in patients with benign and malignant breast lesions and delay of mammary tumor growth in P0-vaccinated mice, Cancer Science, 2011, 102, 3Direct Link:
- 28, , The role of surgery in metastatic breast cancer, European Journal of Cancer, 2011, 47, S6
- 29, , , , , , Treatment of metastatic breast cancer: State-of-the-art, subtypes and perspectives, Critical Reviews in Oncology/Hematology, 2011, 80, 3, 433
- 30, Trends in improving survival in breast cancer: two steps forward but one step back?, Breast Cancer Research and Treatment, 2011, 128, 3, 807
- 31, , , , , , , Ultrasound-guided thermal radiofrequency ablation (RFA) as an adjunct to systemic chemotherapy for breast cancer liver metastases, La radiologia medica, 2011, 116, 7, 1059
- 32, , , , , , , , , , , , , , , Analysis of overall survival from a phase III study of ixabepilone plus capecitabine versus capecitabine in patients with MBC resistant to anthracyclines and taxanes, Breast Cancer Research and Treatment, 2010, 122, 2, 409
- 33, , , , , , , , , , , Chemotherapy for metastatic breast cancer. Comparison of clinical practice and cost of drugs in two cohorts of patients: 1994–1998 and 2003–2006, Breast Cancer Research and Treatment, 2010, 128, 1, 187
- 34, , , , , , , , , , , , , , , , , , , , , Current standards in the treatment of metastatic breast cancer with focus on Lapatinib: a review by a Central European Consensus Panel, Wiener klinische Wochenschrift, 2010, 122, 11-12, 368
- 35, , , , , Effects of Surgical Excision on Survival of Patients with Stage IV Breast Cancer, Journal of Surgical Research, 2010, 161, 1, 83
- 36, , , , First-line chemotherapy with or without biologic agents for metastatic breast cancer, Critical Reviews in Oncology/Hematology, 2010, 76, 2, 99
- 37, , , , , , , , , International Guidelines for Management of Metastatic Breast Cancer: Can Metastatic Breast Cancer Be Cured?, JNCI Journal of the National Cancer Institute, 2010, 102, 7, 456
- 38, , Les grands challenges de la prise en charge en phase métastatique aujourd’hui, Oncologie, 2010, 12, 4, 278
- 39, Lessons Learned From the Metastatic Breast Cancer Community, Seminars in Oncology Nursing, 2010, 26, 3, 195
- 40, , , , , , , Living with metastatic breast cancer: a global patient survey, Community Oncology, 2010, 7, 9, 406
- 41, , , , Local and Systemic Recurrence is the Achilles Heel of Cancer Surgery, Annals of Surgical Oncology, 2010, 18, 3, 603
- 42, , , Multimodale Therapiekonzepte beim metastasierten Mammakarzinom, Der Internist, 2010, 51, 11, 1358
- 43, , , , , , , , , , Phase II study evaluating the efficacy and safety of sagopilone (ZK-EPO) in patients with metastatic breast cancer that has progressed following chemotherapy, Breast Cancer Research and Treatment, 2010, 123, 3, 837
- 44, , , , , , , Quality of Life, Anxiety, and Oncological Factors: A Follow-Up Study of Breast Cancer Patients, Psychosomatics, 2010, 51, 2, 112
- 45, , , , , Survival differences among women with de novo stage IV and relapsed breast cancer, Annals of Oncology, 2010, 21, 11, 2169
- 46, , , , , , , , , , , , , , , , , , The Impact of Primary Tumor Resection on the Survival of Patients with Stage IV Breast Cancer, Journal of Breast Cancer, 2010, 13, 1, 90
- 47, , , , , , The PHSCN dendrimer as a more potent inhibitor of human breast cancer cell invasion, extravasation, and lung colony formation, Breast Cancer Research and Treatment, 2010, 125, 2, 363
- 48, , Treatment of metastatic breast cancer: second line and beyond, Annals of Oncology, 2010, 22, 5, 1000
- 49, Treatment strategy for metastatic breast cancer according to intrinsic subtype, International Journal of Clinical Oncology, 2010, 15, 4, 333
- 50, , , , , , , , , , , , , Clinical perspectives on the utility of aromatase inhibitors for the adjuvant treatment of breast cancer, The Breast, 2009, 18, S1
- 51, , , , , , , , , , , , , , , Disparities in the survival improvement of recurrent breast cancer, Breast Cancer, 2009, 17, 1, 48
- 52, , , , , Fifteen-year trends in metastatic breast cancer survival in Greece, Breast Cancer Research and Treatment, 2009, 119, 3, 621
- 53, Importance of the development time of isolated bone metastasis in breast cancer, Langenbeck's Archives of Surgery, 2009,
- 54, , , , , , , , , , International Guidelines for Management of Metastatic Breast Cancer: Combination vs Sequential Single-Agent Chemotherapy, JNCI Journal of the National Cancer Institute, 2009, 101, 17, 1174
- 55
- 56, , , , , , , , , , , N0332 phase 2 trial of weekly irinotecan hydrochloride and docetaxel in refractory metastatic breast cancer: a North Central Cancer Treatment Group (NCCTG) Trial, Annals of Oncology, 2009, 21, 3, 493
- 57, , , , , , , , , , , Phase II multicenter, uncontrolled trial of sorafenib in patients with metastatic breast cancer, Anti-Cancer Drugs, 2009, 20, 7, 616
- 58, , , , , , , , , , , , , , , Proliferative genes dominate malignancy-risk gene signature in histologically-normal breast tissue, Breast Cancer Research and Treatment, 2009, 119, 2, 335
- 59, , Prolonged Disease Control in a Patient With Anthracycline- and Taxane-Resistant Breast Cancer, Clinical Breast Cancer, 2009, 9, 4, E1
- 60, , , , , , , , , Survival Impact of Integrative Cancer Care in Advanced Metastatic Breast Cancer, The Breast Journal, 2009, 15, 4Direct Link:
- 61, , The follow-up of women at high risk for breast cancer relapse, The Breast, 2009, 18, S74
- 62, The role of surgery in breast cancer patients with isolated bone metastases at the time of diagnosis, Journal of Surgical Oncology, 2009, 100, 2Direct Link:
- 63, , , , , , , , Treatment of Metastatic Carcinoma to the Hip with CT-guided Percutaneous Acetabuloplasty: Report of Four Cases, Journal of Vascular and Interventional Radiology, 2009, 20, 4, 548
- 64, , , , , Adaptation of the Herdecke Quality of Life questionnaire towards quality of life of cancer patients, European Journal of Cancer Care, 2008, 17, 6Direct Link:
- 65, , , , An Update on Prognosis in Breast Cancer Patients with Extensive Axillary Disease, The Breast Journal, 2008, 14, 1Direct Link:
- 66, , Breast cancer follow-up in the adjuvant setting, Current Oncology Reports, 2008, 10, 1, 38
- 67, , , , , , , , , , Circulating tumor cells in metastatic breast cancer, Cancer, 2008, 113, 9Direct Link:
- 68, CirugÃa del tumor primario en cáncer de mama metastásico: ¿podemos contribuir a mejorar la supervivencia?, CirugÃa Española, 2008, 83, 2, 61
- 69
- 70, , Emerging Agents in the Treatment of Anthracycline- and Taxane-Refractory Metastatic Breast Cancer, Seminars in Oncology, 2008, 35, S31
- 71, , , Estimating survival in newly diagnosed cancer patients: Use of computer simulations to evaluate performances of different approaches in a wide range of scenarios, Statistics in Medicine, 2008, 27, 12Direct Link:
- 72, Impact, mechanisms, and novel chemotherapy strategies for overcoming resistance to anthracyclines and taxanes in metastatic breast cancer, Breast Cancer Research and Treatment, 2008, 114, 2, 195
- 73, , , , , Matched Pair Analyses of Stage IV Breast Cancer with or Without Resection of Primary Breast Site, Annals of Surgical Oncology, 2008, 15, 12, 3384
- 74, New Therapeutic Options for Chemotherapy-Resistant Metastatic Breast Cancer, Drugs, 2008, 68, 2, 139
- 75, , Nonhormonal Systemic Therapy for Advanced Breast Cancer: Do the Math!, JNCI Journal of the National Cancer Institute, 2008, 100, 24, 1745
- 76, , , , , , , , , Phase II multicenter study of larotaxel (XRP9881), a novel taxoid, in patients with metastatic breast cancer who previously received taxane-based therapy, Annals of Oncology, 2008, 19, 7, 1255
- 77, , , , , Radioisotopes and vertebral augmentation: Dosimetric analysis of a novel approach for the treatment of malignant compression fractures, Radiotherapy and Oncology, 2008, 87, 1, 119
- 78, , , , , , Stepwise examination for differential diagnosis of primary lung cancer and breast cancer relapse presenting as a solitary pulmonary nodule in patients after mastectomy, Journal of Surgical Oncology, 2008, 98, 7Direct Link:
- 79, , , Surveillance après traitement des cancers du sein localisés invasifs, Gynécologie Obstétrique & Fertilité, 2008, 36, 2, 183
- 80, , , , , , Survival in patients with brain metastases from breast cancer, Cancer, 2008, 112, 11Direct Link:
- 81, The 2007 Rome Forum on the Treatment of Breast Cancer: first-line treatment choices for metastatic breast cancer in Europe, European Journal of Cancer Supplements, 2008, 6, 8, 1
- 82
- 83, , Time to Remove the Subspecialty Blinders: Breast Cancer Does Not Exist in Isolation, JNCI Journal of the National Cancer Institute, 2008, 100, 4, 230
- 84
- 85, , , , , Alterations of Metastasis-Related Genes Identified Using an Oligonucleotide Microarray of Genistein-Treated HCC1395 Breast Cancer Cells, Nutrition and Cancer, 2007, 58, 2, 239
- 86, , , Bisphosphonates for Breast Cancer: Questions Answered, Questions Remaining, Hematology/Oncology Clinics of North America, 2007, 21, 2, 341
- 87, , , Controversies of chemotherapy for the treatment of metastatic breast cancer, European Journal of Cancer Supplements, 2007, 5, 1, 11
- 88, , , , , , , , , Favourable long-term results after surgical removal of lung metastases of breast cancer, Breast Cancer Research and Treatment, 2007, 110, 3, 485
- 89, Genetic polymorphisms and metastatic breast cancer survival, Future Oncology, 2007, 3, 2, 155
- 90, , Has first-line therapy had an impact on general outcome in metastatic breast cancer?, Future Oncology, 2007, 3, 4, 411
- 91, , , , , , , Impact of chemotherapy beyond the first line in patients with metastatic breast cancer, Breast Cancer Research and Treatment, 2007, 107, 2, 275
- 92, Improved survival in metastatic breast cancer following total excision of the primary tumor, Nature Clinical Practice Oncology, 2007, 4, 1, 14
- 93, , , , , , , , Intra-hepatic Mitomycin C bolus infusion in the treatment of extensive liver metastases of breast cancer, Breast Cancer Research and Treatment, 2007, 110, 1, 135
- 94
- 95, , Locoregional Resection in Stage IV Breast Cancer: Tumor Biology, Molecular and Clinical Perspectives, Surgical Clinics of North America, 2007, 87, 2, 527
- 96, , , , , , , , , Mediators of vascular remodelling co-opted for sequential steps in lung metastasis, Nature, 2007, 446, 7137, 765
- 97, , Program Surveillance in Women with Early Breast Cancer – Pro, Breast Care, 2007, 2, 6, 352
- 98, , , , , , , , Quantitative exploration of possible reasons for the recent improvement in breast cancer survival, Breast Cancer Research and Treatment, 2007, 106, 3, 419
- 99, , , , , , , Radiofrequency Ablation of Liver Metastases from Breast Cancer: Results in 14 Patients, Journal of Vascular and Interventional Radiology, 2007, 18, 1, 67
- 100, , , Recent perspectives of endocrine therapy for breast cancer, Breast Cancer, 2007, 14, 2, 194
- 101, , , , , Surgery for palliation and treatment of advanced breast cancer, Surgical Oncology, 2007, 16, 4, 249
- 102, , , , , , , , , , The impact of new chemotherapeutic and hormone agents on survival in a population-based cohort of women with metastatic breast cancer, Cancer, 2007, 110, 5Direct Link:
- 103, , , The significance of the site of recurrence to subsequent breast cancer survival, European Journal of Surgical Oncology (EJSO), 2007, 33, 4, 420
- 104, , Current State of the Treatment in Metastatic Breast Cancer, Journal of Breast Cancer, 2006, 9, 1, 4
- 105, , , , Disease-specific and event-free survival in breast cancer patients: a hospital-based study between 1990 and 2001, Revue d'Épidémiologie et de Santé Publique, 2006, 54, 4, 313
- 106, , , , , , , , , , , , Effect of Primary Tumor Extirpation in Breast Cancer Patients Who Present With Stage IV Disease and an Intact Primary Tumor, Annals of Surgical Oncology, 2006, 13, 6, 776
- 107, , Management of malignant glioma: steady progress with multimodal approaches, Neurosurgical FOCUS, 2006, 20, 4, E3
- 108, , , , , , , , , Patterns of breast cancer relapse, European Journal of Surgical Oncology (EJSO), 2006, 32, 9, 922
- 109, , , , , , , , , , , , Phase II trial of 10-EDAM in the treatment of metastatic breast cancer, Cancer Chemotherapy and Pharmacology, 2006, 60, 1, 61
- 110, , , , Progressive disease in patients with cancer presenting to an emergency room with acute symptoms predicts short-term mortality, Supportive Care in Cancer, 2006, 14, 10, 1038
- 111, , , , , , , , , , Ten years of experience with weekly chemotherapy in metastatic breast cancer patients: multivariate analysis of prognostic factors, Anti-Cancer Drugs, 2006, 17, 10, 1193
- 112, , , , , , , , , , The «El Ãlamo» project (1990–1997): two consecutive hospital-based studies of breast cancer outcomes in Spain, Clinical and Translational Oncology, 2006, 8, 7, 508
- 113, , The role of surgery for pulmonary metastases in breast cancer patients, Breast Cancer Online, 2006, 9, 08
- 114, 1–40 Breast Cancer With Synchronous Metastases: Trends in Survival During a 14-Year Period, Breast Diseases: A Year Book Quarterly, 2005, 16, 1, 76
- 115, , , , , , , Adjuvant systemic therapy for male breast carcinoma, Cancer, 2005, 104, 11Direct Link:
- 116, , , , Angiosarcoma after breast-conserving therapy: Fine-needle aspiration biopsy, immunocytochemistry, and clinicopathologic correlates, Cancer Cytopathology, 2005, 105, 3Direct Link:
- 117, , Development of Novel Chemotherapeutic Agents to Evade the Mechanisms of Multidrug Resistance (MDR), Seminars in Oncology, 2005, 32, 22
- 118
- 119, , , , , , , , , , Multicenter phase II study of trastuzumab in combination with epirubicin and docetaxel as first-line treatment for HER2-overexpressing metastatic breast cancer, Breast Cancer Research and Treatment, 2005, 95, 1, 45
- 120, , , , , , , , , Risk for recurrence and death from preexisting cancers after transplantation, Transplantation Reviews, 2005, 19, 3, 151
- 121, , , , , Survival of metastatic breast carcinoma patients over a 20-year period, Cancer, 2005, 104, 8Direct Link:
- 122, Place actuelle des dosages du CA 15.3 dans le cancer du sein, Immuno-analyse & Biologie Spécialisée, 2004, 19, 5, 274
- 123, , , , , , , , , , , , The role of the liposomal anthracyclines and other systemic therapies in the management of advanced breast cancer, Seminars in Oncology, 2004, 31, 106
- 124, , , , , Combination versus sequential single agent chemotherapy for metastatic breast cancer, The Cochrane Library,Direct Link: